Skip to main content
NIH funding notice PAR-23-074

In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed)

Closed on November 5, 2024.

Posted
January 12, 2023
Close date
November 5, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $325,000 in first-year total cost, median $325,000.

Most frequent study sections

  1. Development - 2 Study Section[DEV2]1

Most frequent institutions

  1. UNIVERSITY OF MASSACHUSETTS AMHERST1
Competing awards under PAR-23-074 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Streamline assessment of early lethal phenotypes in the mouse2R56HD083311-11A1MAGER, JESSEUNIVERSITY OF MASSACHUSETTS AMHERST, MA$325,000DEV2

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.